Clinical Trial Update: Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008) [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating histone deacetylase inhibitors for metastatic gastric cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Technical University of Munich | Conditions: Metastatic Gastric Cancer | Phase 2 | Status: TERMINATED